Reviewed clinical summary · Source-linked · Educational use only

Can a Personalized Education Model Improve Diabetes Management?

Clinical Bottom Line

A cluster RCT finds a structured personalised education model markedly improves glycaemic control in type 2 diabetes, though intensity limits generalisability. PICO summary and commentary.

Summary: In community-based adults with type 2 diabetes, a structured personalised education model (CAPDCA) delivered over 18 months markedly improved HbA1c target achievement (83.3% vs 25.0%), glycaemic control, medication adherence, and quality of life compared with traditional education.

PICO Summary

ElementDetail
Population180 adults with type 2 diabetes at six Beijing community health centres (178 completed; cluster RCT).
InterventionCAPDCA personalised, iterative education over 18 months across 11 visits (n=90).
ComparisonTraditional diabetes education without personalisation or iterative feedback (n=88).
OutcomeHbA1c target achievement 83.3% vs 25.0% (RR 3.33; 95% CI 2.29–4.84), greater HbA1c fall (P<0.01), greater FBG and 2h-PPG reductions, improved MMAS-8 adherence and SF-36 quality of life (all P<0.01).
RCT Fam Pract · 2025

CAPDCA personalised education in type 2 diabetes

Cluster RCT · type 2 diabetes · 18 months

Trial design
Adults with T2D (community) Enrolled & assessed RANDOMISED Cluster CAPDCA Personalised education n = 90 Control Traditional education n = 88 HbA1c target achievement at 18 months
Proportion reaching endpoint
RR 3.33 % reaching HbA1c target 83.3% CAPDCA 25% Control ARRARR 58.3%
Reached target
83.3%
CAPDCA
Reached target
25.0%
Control
Risk ratio
3.33
95% CI 2.29-4.84
Completed
178/180
Cluster RCT
⬡ Bottom Line

Personalised iterative education tripled HbA1c target achievement versus traditional education (83.3% vs 25.0%), but the very large effect likely reflects the intensity of 11 visits over 18 months.

Expert Commentary

Nobody doubts that structured, personalised education helps in diabetes, so the direction of this trial is unsurprising and welcome, and it fits comfortably alongside DESMOND and X-PERT and the ADA’s longstanding emphasis on self-management support. What gives me pause is the sheer size of the effect: an HbA1c target-achievement rate of 83% against 25% is far larger than this literature usually delivers, and I think the explanation lies less in the model’s cleverness than in its intensity. Eleven visits over eighteen months is a vast attention difference from standard care, which an unblindable education trial cannot separate from Hawthorne and performance effects, and the single-centre Beijing setting limits generalisability. Outcomes were also surrogate or self-reported, without complication endpoints. Can I use this with my patients? Yes, in its principles rather than its full apparatus: individualised assessment, tailored goals, scheduled follow-up, explicit feedback loops, reserved for patients struggling to reach target. But I would not promise an 83% success rate, and I would want pragmatic replication in a busier, less resource-rich system before believing the magnitude transfers.

References

Li J, Xing W, Liu YJ, Jiang Y. Effect of collection-assessment-plan-do-check-aggrandizement model of personalized patient education in patients with diabetes: a cluster randomized controlled study. Fam Pract. 2025;42(6):cmaf086. doi:10.1093/fampra/cmaf086

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.